nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoricoxib—CYP2E1—Amitriptyline—migraine	0.0603	0.0845	CbGbCtD
Etoricoxib—CYP2C19—Timolol—migraine	0.0491	0.0687	CbGbCtD
Etoricoxib—CYP2C19—Propranolol—migraine	0.0437	0.0612	CbGbCtD
Etoricoxib—CYP1A2—Propranolol—migraine	0.0403	0.0565	CbGbCtD
Etoricoxib—CYP2C19—Amitriptyline—migraine	0.0378	0.053	CbGbCtD
Etoricoxib—CYP2D6—Timolol—migraine	0.0373	0.0522	CbGbCtD
Etoricoxib—CYP1A2—Amitriptyline—migraine	0.0349	0.0489	CbGbCtD
Etoricoxib—CYP2C19—Valproic Acid—migraine	0.0345	0.0483	CbGbCtD
Etoricoxib—CYP2D6—Propranolol—migraine	0.0332	0.0465	CbGbCtD
Etoricoxib—CYP1A2—Valproic Acid—migraine	0.0318	0.0445	CbGbCtD
Etoricoxib—CYP2C9—Amitriptyline—migraine	0.0314	0.044	CbGbCtD
Etoricoxib—CYP2C19—Topiramate—migraine	0.0311	0.0435	CbGbCtD
Etoricoxib—CYP2C19—Verapamil—migraine	0.03	0.042	CbGbCtD
Etoricoxib—CYP2D6—Amitriptyline—migraine	0.0287	0.0403	CbGbCtD
Etoricoxib—CYP2C9—Valproic Acid—migraine	0.0287	0.0401	CbGbCtD
Etoricoxib—CYP1A2—Verapamil—migraine	0.0277	0.0388	CbGbCtD
Etoricoxib—CYP2C9—Verapamil—migraine	0.0249	0.0349	CbGbCtD
Etoricoxib—CYP2D6—Verapamil—migraine	0.0228	0.0319	CbGbCtD
Etoricoxib—CYP3A4—Propranolol—migraine	0.0211	0.0296	CbGbCtD
Etoricoxib—CYP3A4—Amitriptyline—migraine	0.0183	0.0256	CbGbCtD
Etoricoxib—CYP3A4—Valproic Acid—migraine	0.0167	0.0233	CbGbCtD
Etoricoxib—CYP3A4—Topiramate—migraine	0.015	0.0211	CbGbCtD
Etoricoxib—CYP3A4—Verapamil—migraine	0.0145	0.0203	CbGbCtD
Etoricoxib—MAPK14—CDO in myogenesis—MEF2D—migraine	0.00128	0.0573	CbGpPWpGaD
Etoricoxib—MAPK14—p38 MAPK Signaling Pathway—MEF2D—migraine	0.00113	0.0504	CbGpPWpGaD
Etoricoxib—MAPK14—blood vessel—migraine	0.000983	0.157	CbGeAlD
Etoricoxib—MAPK14—Role of Calcineurin-dependent NFAT signaling in lymphocytes—MEF2D—migraine	0.000778	0.0348	CbGpPWpGaD
Etoricoxib—MAPK14—Mitochondrial biogenesis—MEF2D—migraine	0.000778	0.0348	CbGpPWpGaD
Etoricoxib—MAPK14—Activation of the AP-1 family of transcription factors—FOS—migraine	0.000739	0.0331	CbGpPWpGaD
Etoricoxib—MAPK14—neck—migraine	0.000703	0.112	CbGeAlD
Etoricoxib—MAPK14—IL4-mediated signaling events—LTA—migraine	0.000697	0.0312	CbGpPWpGaD
Etoricoxib—CYP2E1—Folate-Alcohol and Cancer Pathway—MTHFR—migraine	0.000603	0.027	CbGpPWpGaD
Etoricoxib—MAPK14—Monoamine Transport—SLC6A4—migraine	0.000594	0.0266	CbGpPWpGaD
Etoricoxib—MAPK14—brainstem—migraine	0.000538	0.0859	CbGeAlD
Etoricoxib—MAPK14—FSH signaling pathway—BDNF—migraine	0.000494	0.0221	CbGpPWpGaD
Etoricoxib—MAPK14—B Cell Receptor Signaling Pathway—MEF2D—migraine	0.000487	0.0218	CbGpPWpGaD
Etoricoxib—MAPK14—cardiovascular system—migraine	0.000439	0.0701	CbGeAlD
Etoricoxib—MAPK14—Estrogen signaling pathway—ESR1—migraine	0.000421	0.0188	CbGpPWpGaD
Etoricoxib—PTGS2—Prostaglandin Synthesis and Regulation—EDNRA—migraine	0.000389	0.0174	CbGpPWpGaD
Etoricoxib—MAPK14—Estrogen signaling pathway—FOS—migraine	0.000379	0.017	CbGpPWpGaD
Etoricoxib—MAPK14—Physiological and Pathological Hypertrophy  of the Heart—FOS—migraine	0.000355	0.0159	CbGpPWpGaD
Etoricoxib—MAPK14—Organelle biogenesis and maintenance—MEF2D—migraine	0.000353	0.0158	CbGpPWpGaD
Etoricoxib—MAPK14—S1P2 pathway—FOS—migraine	0.000344	0.0154	CbGpPWpGaD
Etoricoxib—MAPK14—Endothelins—EDNRA—migraine	0.000336	0.015	CbGpPWpGaD
Etoricoxib—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—FOS—migraine	0.000324	0.0145	CbGpPWpGaD
Etoricoxib—MAPK14—EGF/EGFR Signaling Pathway—MEF2D—migraine	0.000323	0.0145	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK targets/ Nuclear events mediated by MAP kinases—FOS—migraine	0.000307	0.0137	CbGpPWpGaD
Etoricoxib—MAPK14—Oxidative Stress—FOS—migraine	0.000307	0.0137	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling mediated by p38-alpha and p38-beta—ESR1—migraine	0.000301	0.0135	CbGpPWpGaD
Etoricoxib—MAPK14—head—migraine	0.000297	0.0475	CbGeAlD
Etoricoxib—PTGS2—blood vessel—migraine	0.000283	0.0452	CbGeAlD
Etoricoxib—MAPK14—nervous system—migraine	0.000282	0.045	CbGeAlD
Etoricoxib—MAPK14—Trk receptor signaling mediated by the MAPK pathway—FOS—migraine	0.000278	0.0124	CbGpPWpGaD
Etoricoxib—MAPK14—central nervous system—migraine	0.000271	0.0433	CbGeAlD
Etoricoxib—Angioedema—Valproic Acid—migraine	0.000266	0.00103	CcSEcCtD
Etoricoxib—Photosensitivity reaction—Topiramate—migraine	0.000266	0.00103	CcSEcCtD
Etoricoxib—Arrhythmia—Timolol—migraine	0.000266	0.00103	CcSEcCtD
Etoricoxib—Nausea—Amitriptyline—migraine	0.000266	0.00103	CcSEcCtD
Etoricoxib—Weight increased—Topiramate—migraine	0.000265	0.00103	CcSEcCtD
Etoricoxib—MAPK14—cerebellum—migraine	0.000265	0.0424	CbGeAlD
Etoricoxib—Alopecia—Timolol—migraine	0.000263	0.00102	CcSEcCtD
Etoricoxib—Hyperglycaemia—Topiramate—migraine	0.000263	0.00102	CcSEcCtD
Etoricoxib—Erythema multiforme—Gabapentin—migraine	0.000262	0.00102	CcSEcCtD
Etoricoxib—Asthenia—Propranolol—migraine	0.000261	0.00102	CcSEcCtD
Etoricoxib—Pneumonia—Topiramate—migraine	0.000261	0.00102	CcSEcCtD
Etoricoxib—Mental disorder—Timolol—migraine	0.000261	0.00101	CcSEcCtD
Etoricoxib—Infestation NOS—Topiramate—migraine	0.00026	0.00101	CcSEcCtD
Etoricoxib—Infestation—Topiramate—migraine	0.00026	0.00101	CcSEcCtD
Etoricoxib—Malnutrition—Timolol—migraine	0.000259	0.00101	CcSEcCtD
Etoricoxib—Erythema—Timolol—migraine	0.000259	0.00101	CcSEcCtD
Etoricoxib—Eye disorder—Gabapentin—migraine	0.000259	0.00101	CcSEcCtD
Etoricoxib—Tinnitus—Gabapentin—migraine	0.000258	0.001	CcSEcCtD
Etoricoxib—Stevens-Johnson syndrome—Topiramate—migraine	0.000258	0.001	CcSEcCtD
Etoricoxib—Cardiac disorder—Gabapentin—migraine	0.000257	0.001	CcSEcCtD
Etoricoxib—Palpitations—Valproic Acid—migraine	0.000257	0.001	CcSEcCtD
Etoricoxib—Renal failure—Topiramate—migraine	0.000255	0.000992	CcSEcCtD
Etoricoxib—Neuropathy peripheral—Topiramate—migraine	0.000255	0.00099	CcSEcCtD
Etoricoxib—Cough—Valproic Acid—migraine	0.000254	0.000987	CcSEcCtD
Etoricoxib—Dysgeusia—Timolol—migraine	0.000254	0.000986	CcSEcCtD
Etoricoxib—Stomatitis—Topiramate—migraine	0.000253	0.000984	CcSEcCtD
Etoricoxib—Conjunctivitis—Topiramate—migraine	0.000253	0.000981	CcSEcCtD
Etoricoxib—Urinary tract infection—Topiramate—migraine	0.000253	0.000981	CcSEcCtD
Etoricoxib—Hypertension—Valproic Acid—migraine	0.000251	0.000977	CcSEcCtD
Etoricoxib—Immune system disorder—Gabapentin—migraine	0.00025	0.000973	CcSEcCtD
Etoricoxib—Mediastinal disorder—Gabapentin—migraine	0.00025	0.000971	CcSEcCtD
Etoricoxib—Diarrhoea—Propranolol—migraine	0.000249	0.000968	CcSEcCtD
Etoricoxib—Chest pain—Valproic Acid—migraine	0.000248	0.000963	CcSEcCtD
Etoricoxib—Arthralgia—Valproic Acid—migraine	0.000248	0.000963	CcSEcCtD
Etoricoxib—Haematuria—Topiramate—migraine	0.000248	0.000963	CcSEcCtD
Etoricoxib—Anxiety—Valproic Acid—migraine	0.000247	0.00096	CcSEcCtD
Etoricoxib—Hypersensitivity—Verapamil—migraine	0.000247	0.000959	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.000246	0.000956	CcSEcCtD
Etoricoxib—Epistaxis—Topiramate—migraine	0.000245	0.000952	CcSEcCtD
Etoricoxib—Alopecia—Gabapentin—migraine	0.000245	0.000952	CcSEcCtD
Etoricoxib—Vision blurred—Timolol—migraine	0.000244	0.000949	CcSEcCtD
Etoricoxib—Sinusitis—Topiramate—migraine	0.000244	0.000947	CcSEcCtD
Etoricoxib—Mental disorder—Gabapentin—migraine	0.000243	0.000944	CcSEcCtD
Etoricoxib—Dry mouth—Valproic Acid—migraine	0.000242	0.000942	CcSEcCtD
Etoricoxib—Erythema—Gabapentin—migraine	0.000241	0.000938	CcSEcCtD
Etoricoxib—Malnutrition—Gabapentin—migraine	0.000241	0.000938	CcSEcCtD
Etoricoxib—Dizziness—Propranolol—migraine	0.000241	0.000936	CcSEcCtD
Etoricoxib—Asthenia—Verapamil—migraine	0.00024	0.000934	CcSEcCtD
Etoricoxib—CYP1A2—Estrogen Receptor Pathway—ESR1—migraine	0.00024	0.0108	CbGpPWpGaD
Etoricoxib—Confusional state—Valproic Acid—migraine	0.00024	0.000931	CcSEcCtD
Etoricoxib—Flatulence—Gabapentin—migraine	0.000238	0.000924	CcSEcCtD
Etoricoxib—Anaphylactic shock—Valproic Acid—migraine	0.000238	0.000923	CcSEcCtD
Etoricoxib—Oedema—Valproic Acid—migraine	0.000238	0.000923	CcSEcCtD
Etoricoxib—Pruritus—Verapamil—migraine	0.000237	0.000921	CcSEcCtD
Etoricoxib—Angioedema—Timolol—migraine	0.000237	0.00092	CcSEcCtD
Etoricoxib—Dysgeusia—Gabapentin—migraine	0.000236	0.000918	CcSEcCtD
Etoricoxib—Infection—Valproic Acid—migraine	0.000236	0.000917	CcSEcCtD
Etoricoxib—Haemoglobin—Topiramate—migraine	0.000234	0.000911	CcSEcCtD
Etoricoxib—Hepatitis—Topiramate—migraine	0.000233	0.000906	CcSEcCtD
Etoricoxib—Haemorrhage—Topiramate—migraine	0.000233	0.000906	CcSEcCtD
Etoricoxib—Nervous system disorder—Valproic Acid—migraine	0.000233	0.000905	CcSEcCtD
Etoricoxib—Thrombocytopenia—Valproic Acid—migraine	0.000233	0.000904	CcSEcCtD
Etoricoxib—Hypoaesthesia—Topiramate—migraine	0.000232	0.000902	CcSEcCtD
Etoricoxib—Hallucination—Topiramate—migraine	0.000232	0.000902	CcSEcCtD
Etoricoxib—Muscle spasms—Gabapentin—migraine	0.000232	0.000902	CcSEcCtD
Etoricoxib—Vomiting—Propranolol—migraine	0.000232	0.0009	CcSEcCtD
Etoricoxib—Pharyngitis—Topiramate—migraine	0.000231	0.000899	CcSEcCtD
Etoricoxib—Skin disorder—Valproic Acid—migraine	0.000231	0.000897	CcSEcCtD
Etoricoxib—Urinary tract disorder—Topiramate—migraine	0.00023	0.000895	CcSEcCtD
Etoricoxib—Oedema peripheral—Topiramate—migraine	0.00023	0.000893	CcSEcCtD
Etoricoxib—Rash—Propranolol—migraine	0.00023	0.000892	CcSEcCtD
Etoricoxib—Dermatitis—Propranolol—migraine	0.000229	0.000892	CcSEcCtD
Etoricoxib—Diarrhoea—Verapamil—migraine	0.000229	0.000891	CcSEcCtD
Etoricoxib—Connective tissue disorder—Topiramate—migraine	0.000229	0.000891	CcSEcCtD
Etoricoxib—Palpitations—Timolol—migraine	0.000229	0.00089	CcSEcCtD
Etoricoxib—Urethral disorder—Topiramate—migraine	0.000229	0.000888	CcSEcCtD
Etoricoxib—Vision blurred—Gabapentin—migraine	0.000227	0.000884	CcSEcCtD
Etoricoxib—Anorexia—Valproic Acid—migraine	0.000226	0.00088	CcSEcCtD
Etoricoxib—Cough—Timolol—migraine	0.000226	0.000879	CcSEcCtD
Etoricoxib—Tremor—Gabapentin—migraine	0.000226	0.000879	CcSEcCtD
Etoricoxib—Visual impairment—Topiramate—migraine	0.000225	0.000873	CcSEcCtD
Etoricoxib—Hypertension—Timolol—migraine	0.000224	0.000869	CcSEcCtD
Etoricoxib—Anaemia—Gabapentin—migraine	0.000223	0.000867	CcSEcCtD
Etoricoxib—Agitation—Gabapentin—migraine	0.000222	0.000862	CcSEcCtD
Etoricoxib—Dizziness—Verapamil—migraine	0.000222	0.000861	CcSEcCtD
Etoricoxib—Arthralgia—Timolol—migraine	0.000221	0.000857	CcSEcCtD
Etoricoxib—Chest pain—Timolol—migraine	0.000221	0.000857	CcSEcCtD
Etoricoxib—Erythema multiforme—Topiramate—migraine	0.000221	0.000857	CcSEcCtD
Etoricoxib—Angioedema—Gabapentin—migraine	0.00022	0.000857	CcSEcCtD
Etoricoxib—Anxiety—Timolol—migraine	0.00022	0.000854	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.000219	0.000851	CcSEcCtD
Etoricoxib—Eye disorder—Topiramate—migraine	0.000218	0.000847	CcSEcCtD
Etoricoxib—Tinnitus—Topiramate—migraine	0.000217	0.000845	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Valproic Acid—migraine	0.000216	0.000841	CcSEcCtD
Etoricoxib—Flushing—Topiramate—migraine	0.000216	0.000841	CcSEcCtD
Etoricoxib—Cardiac disorder—Topiramate—migraine	0.000216	0.000841	CcSEcCtD
Etoricoxib—Nausea—Propranolol—migraine	0.000216	0.000841	CcSEcCtD
Etoricoxib—Dry mouth—Timolol—migraine	0.000216	0.000838	CcSEcCtD
Etoricoxib—MAPK14—brain—migraine	0.000215	0.0344	CbGeAlD
Etoricoxib—Insomnia—Valproic Acid—migraine	0.000215	0.000835	CcSEcCtD
Etoricoxib—MAPK14—Structural Pathway of Interleukin 1 (IL-1)—FOS—migraine	0.000214	0.00959	CbGpPWpGaD
Etoricoxib—MAPK14—IL6-mediated signaling events—FOS—migraine	0.000214	0.00959	CbGpPWpGaD
Etoricoxib—Palpitations—Gabapentin—migraine	0.000213	0.000829	CcSEcCtD
Etoricoxib—Confusional state—Timolol—migraine	0.000213	0.000829	CcSEcCtD
Etoricoxib—Vomiting—Verapamil—migraine	0.000213	0.000828	CcSEcCtD
Etoricoxib—Dyspnoea—Valproic Acid—migraine	0.000212	0.000823	CcSEcCtD
Etoricoxib—Angiopathy—Topiramate—migraine	0.000212	0.000822	CcSEcCtD
Etoricoxib—Oedema—Timolol—migraine	0.000211	0.000822	CcSEcCtD
Etoricoxib—Anaphylactic shock—Timolol—migraine	0.000211	0.000822	CcSEcCtD
Etoricoxib—Rash—Verapamil—migraine	0.000211	0.000821	CcSEcCtD
Etoricoxib—Somnolence—Valproic Acid—migraine	0.000211	0.000821	CcSEcCtD
Etoricoxib—Dermatitis—Verapamil—migraine	0.000211	0.00082	CcSEcCtD
Etoricoxib—Immune system disorder—Topiramate—migraine	0.000211	0.000819	CcSEcCtD
Etoricoxib—Cough—Gabapentin—migraine	0.000211	0.000818	CcSEcCtD
Etoricoxib—Mediastinal disorder—Topiramate—migraine	0.00021	0.000817	CcSEcCtD
Etoricoxib—Infection—Timolol—migraine	0.00021	0.000816	CcSEcCtD
Etoricoxib—Headache—Verapamil—migraine	0.00021	0.000816	CcSEcCtD
Etoricoxib—Dyspepsia—Valproic Acid—migraine	0.000209	0.000813	CcSEcCtD
Etoricoxib—Hypertension—Gabapentin—migraine	0.000208	0.00081	CcSEcCtD
Etoricoxib—Shock—Timolol—migraine	0.000208	0.000809	CcSEcCtD
Etoricoxib—Nervous system disorder—Timolol—migraine	0.000207	0.000806	CcSEcCtD
Etoricoxib—Decreased appetite—Valproic Acid—migraine	0.000207	0.000802	CcSEcCtD
Etoricoxib—Alopecia—Topiramate—migraine	0.000206	0.000801	CcSEcCtD
Etoricoxib—Arthralgia—Gabapentin—migraine	0.000205	0.000798	CcSEcCtD
Etoricoxib—Chest pain—Gabapentin—migraine	0.000205	0.000798	CcSEcCtD
Etoricoxib—Skin disorder—Timolol—migraine	0.000205	0.000798	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Valproic Acid—migraine	0.000205	0.000797	CcSEcCtD
Etoricoxib—Fatigue—Valproic Acid—migraine	0.000205	0.000796	CcSEcCtD
Etoricoxib—Anxiety—Gabapentin—migraine	0.000205	0.000796	CcSEcCtD
Etoricoxib—Mental disorder—Topiramate—migraine	0.000204	0.000794	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.000204	0.000793	CcSEcCtD
Etoricoxib—Constipation—Valproic Acid—migraine	0.000203	0.000789	CcSEcCtD
Etoricoxib—Pain—Valproic Acid—migraine	0.000203	0.000789	CcSEcCtD
Etoricoxib—Erythema—Topiramate—migraine	0.000203	0.000789	CcSEcCtD
Etoricoxib—Malnutrition—Topiramate—migraine	0.000203	0.000789	CcSEcCtD
Etoricoxib—Anorexia—Timolol—migraine	0.000202	0.000783	CcSEcCtD
Etoricoxib—PTGS2—Calcium signaling in the CD4+ TCR pathway—FOS—migraine	0.000201	0.00901	CbGpPWpGaD
Etoricoxib—Dry mouth—Gabapentin—migraine	0.000201	0.000781	CcSEcCtD
Etoricoxib—Flatulence—Topiramate—migraine	0.0002	0.000777	CcSEcCtD
Etoricoxib—Nausea—Verapamil—migraine	0.000199	0.000773	CcSEcCtD
Etoricoxib—Dysgeusia—Topiramate—migraine	0.000199	0.000773	CcSEcCtD
Etoricoxib—Confusional state—Gabapentin—migraine	0.000199	0.000772	CcSEcCtD
Etoricoxib—MAPK14—ATF-2 transcription factor network—ESR1—migraine	0.000198	0.00887	CbGpPWpGaD
Etoricoxib—Oedema—Gabapentin—migraine	0.000197	0.000765	CcSEcCtD
Etoricoxib—Anaphylactic shock—Gabapentin—migraine	0.000197	0.000765	CcSEcCtD
Etoricoxib—Feeling abnormal—Valproic Acid—migraine	0.000196	0.000761	CcSEcCtD
Etoricoxib—Infection—Gabapentin—migraine	0.000196	0.00076	CcSEcCtD
Etoricoxib—Muscle spasms—Topiramate—migraine	0.000195	0.000758	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Valproic Acid—migraine	0.000194	0.000755	CcSEcCtD
Etoricoxib—Shock—Gabapentin—migraine	0.000194	0.000753	CcSEcCtD
Etoricoxib—Nervous system disorder—Gabapentin—migraine	0.000193	0.000751	CcSEcCtD
Etoricoxib—Thrombocytopenia—Gabapentin—migraine	0.000193	0.000749	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Timolol—migraine	0.000193	0.000749	CcSEcCtD
Etoricoxib—PTGS2—Signaling mediated by p38-alpha and p38-beta—ESR1—migraine	0.000192	0.0086	CbGpPWpGaD
Etoricoxib—MAPK14—IL2-mediated signaling events—FOS—migraine	0.000192	0.00858	CbGpPWpGaD
Etoricoxib—MAPK14—FGF signaling pathway—FOS—migraine	0.000192	0.00858	CbGpPWpGaD
Etoricoxib—MAPK14—IL-4 Signaling Pathway—FOS—migraine	0.000192	0.00858	CbGpPWpGaD
Etoricoxib—Vision blurred—Topiramate—migraine	0.000191	0.000743	CcSEcCtD
Etoricoxib—Skin disorder—Gabapentin—migraine	0.000191	0.000743	CcSEcCtD
Etoricoxib—Insomnia—Timolol—migraine	0.000191	0.000743	CcSEcCtD
Etoricoxib—Tremor—Topiramate—migraine	0.00019	0.000739	CcSEcCtD
Etoricoxib—MAPK14—RANKL/RANK Signaling Pathway—FOS—migraine	0.000189	0.00845	CbGpPWpGaD
Etoricoxib—Urticaria—Valproic Acid—migraine	0.000189	0.000733	CcSEcCtD
Etoricoxib—Dyspnoea—Timolol—migraine	0.000189	0.000733	CcSEcCtD
Etoricoxib—Somnolence—Timolol—migraine	0.000188	0.000731	CcSEcCtD
Etoricoxib—Abdominal pain—Valproic Acid—migraine	0.000188	0.00073	CcSEcCtD
Etoricoxib—Anorexia—Gabapentin—migraine	0.000188	0.000729	CcSEcCtD
Etoricoxib—Anaemia—Topiramate—migraine	0.000188	0.000729	CcSEcCtD
Etoricoxib—Agitation—Topiramate—migraine	0.000187	0.000725	CcSEcCtD
Etoricoxib—MAPK14—MAP kinase activation in TLR cascade—FOS—migraine	0.000186	0.00833	CbGpPWpGaD
Etoricoxib—Dyspepsia—Timolol—migraine	0.000186	0.000723	CcSEcCtD
Etoricoxib—Decreased appetite—Timolol—migraine	0.000184	0.000714	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Timolol—migraine	0.000183	0.000709	CcSEcCtD
Etoricoxib—Fatigue—Timolol—migraine	0.000182	0.000709	CcSEcCtD
Etoricoxib—Pain—Timolol—migraine	0.000181	0.000703	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Gabapentin—migraine	0.000179	0.000697	CcSEcCtD
Etoricoxib—Palpitations—Topiramate—migraine	0.000179	0.000697	CcSEcCtD
Etoricoxib—MAPK14—Kit receptor signaling pathway—FOS—migraine	0.000179	0.00799	CbGpPWpGaD
Etoricoxib—MAPK14—ATF-2 transcription factor network—FOS—migraine	0.000179	0.00799	CbGpPWpGaD
Etoricoxib—Insomnia—Gabapentin—migraine	0.000178	0.000692	CcSEcCtD
Etoricoxib—Cough—Topiramate—migraine	0.000177	0.000688	CcSEcCtD
Etoricoxib—MAPK14—IL12-mediated signaling events—FOS—migraine	0.000176	0.00788	CbGpPWpGaD
Etoricoxib—Dyspnoea—Gabapentin—migraine	0.000176	0.000682	CcSEcCtD
Etoricoxib—Hypertension—Topiramate—migraine	0.000175	0.000681	CcSEcCtD
Etoricoxib—Somnolence—Gabapentin—migraine	0.000175	0.00068	CcSEcCtD
Etoricoxib—Hypersensitivity—Valproic Acid—migraine	0.000175	0.00068	CcSEcCtD
Etoricoxib—PTGS2—trigeminal ganglion—migraine	0.000175	0.0279	CbGeAlD
Etoricoxib—Feeling abnormal—Timolol—migraine	0.000174	0.000677	CcSEcCtD
Etoricoxib—Dyspepsia—Gabapentin—migraine	0.000173	0.000674	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Timolol—migraine	0.000173	0.000672	CcSEcCtD
Etoricoxib—Arthralgia—Topiramate—migraine	0.000173	0.000672	CcSEcCtD
Etoricoxib—Chest pain—Topiramate—migraine	0.000173	0.000672	CcSEcCtD
Etoricoxib—Anxiety—Topiramate—migraine	0.000172	0.000669	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	0.000172	0.000667	CcSEcCtD
Etoricoxib—Decreased appetite—Gabapentin—migraine	0.000171	0.000665	CcSEcCtD
Etoricoxib—Asthenia—Valproic Acid—migraine	0.00017	0.000662	CcSEcCtD
Etoricoxib—MAPK14—Developmental Biology—SCN1A—migraine	0.00017	0.00762	CbGpPWpGaD
Etoricoxib—Gastrointestinal disorder—Gabapentin—migraine	0.00017	0.000661	CcSEcCtD
Etoricoxib—Fatigue—Gabapentin—migraine	0.00017	0.00066	CcSEcCtD
Etoricoxib—MAPK14—Endothelins—FOS—migraine	0.000169	0.00758	CbGpPWpGaD
Etoricoxib—Dry mouth—Topiramate—migraine	0.000169	0.000657	CcSEcCtD
Etoricoxib—Pain—Gabapentin—migraine	0.000168	0.000654	CcSEcCtD
Etoricoxib—Constipation—Gabapentin—migraine	0.000168	0.000654	CcSEcCtD
Etoricoxib—Pruritus—Valproic Acid—migraine	0.000168	0.000653	CcSEcCtD
Etoricoxib—Urticaria—Timolol—migraine	0.000168	0.000653	CcSEcCtD
Etoricoxib—Abdominal pain—Timolol—migraine	0.000167	0.00065	CcSEcCtD
Etoricoxib—Confusional state—Topiramate—migraine	0.000167	0.000649	CcSEcCtD
Etoricoxib—Oedema—Topiramate—migraine	0.000166	0.000644	CcSEcCtD
Etoricoxib—MAPK14—Oncostatin M Signaling Pathway—FOS—migraine	0.000165	0.0074	CbGpPWpGaD
Etoricoxib—Infection—Topiramate—migraine	0.000165	0.00064	CcSEcCtD
Etoricoxib—MAPK14—Leptin signaling pathway—ESR1—migraine	0.000164	0.00732	CbGpPWpGaD
Etoricoxib—MAPK14—TSH signaling pathway—FOS—migraine	0.000163	0.00731	CbGpPWpGaD
Etoricoxib—Shock—Topiramate—migraine	0.000163	0.000633	CcSEcCtD
Etoricoxib—Diarrhoea—Valproic Acid—migraine	0.000163	0.000632	CcSEcCtD
Etoricoxib—Nervous system disorder—Topiramate—migraine	0.000162	0.000631	CcSEcCtD
Etoricoxib—Feeling abnormal—Gabapentin—migraine	0.000162	0.000631	CcSEcCtD
Etoricoxib—Thrombocytopenia—Topiramate—migraine	0.000162	0.00063	CcSEcCtD
Etoricoxib—MAPK14—BCR signaling pathway—FOS—migraine	0.000161	0.00722	CbGpPWpGaD
Etoricoxib—Gastrointestinal pain—Gabapentin—migraine	0.000161	0.000626	CcSEcCtD
Etoricoxib—Skin disorder—Topiramate—migraine	0.000161	0.000625	CcSEcCtD
Etoricoxib—Anorexia—Topiramate—migraine	0.000158	0.000614	CcSEcCtD
Etoricoxib—Dizziness—Valproic Acid—migraine	0.000157	0.00061	CcSEcCtD
Etoricoxib—MAPK14—Monoamine Transport—TNF—migraine	0.000157	0.00701	CbGpPWpGaD
Etoricoxib—Urticaria—Gabapentin—migraine	0.000156	0.000608	CcSEcCtD
Etoricoxib—Hypersensitivity—Timolol—migraine	0.000156	0.000605	CcSEcCtD
Etoricoxib—Abdominal pain—Gabapentin—migraine	0.000156	0.000605	CcSEcCtD
Etoricoxib—PTGS2—Aryl Hydrocarbon Receptor—ESR1—migraine	0.000154	0.00691	CbGpPWpGaD
Etoricoxib—PTGS2—Overview of nanoparticle effects—TNF—migraine	0.000152	0.00679	CbGpPWpGaD
Etoricoxib—Asthenia—Timolol—migraine	0.000152	0.00059	CcSEcCtD
Etoricoxib—Vomiting—Valproic Acid—migraine	0.000151	0.000587	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Topiramate—migraine	0.000151	0.000587	CcSEcCtD
Etoricoxib—Insomnia—Topiramate—migraine	0.00015	0.000582	CcSEcCtD
Etoricoxib—Rash—Valproic Acid—migraine	0.00015	0.000582	CcSEcCtD
Etoricoxib—Dermatitis—Valproic Acid—migraine	0.00015	0.000582	CcSEcCtD
Etoricoxib—Pruritus—Timolol—migraine	0.00015	0.000581	CcSEcCtD
Etoricoxib—Headache—Valproic Acid—migraine	0.000149	0.000578	CcSEcCtD
Etoricoxib—Dyspnoea—Topiramate—migraine	0.000148	0.000574	CcSEcCtD
Etoricoxib—MAPK14—TRAF6 Mediated Induction of proinflammatory cytokines—FOS—migraine	0.000147	0.0066	CbGpPWpGaD
Etoricoxib—Somnolence—Topiramate—migraine	0.000147	0.000572	CcSEcCtD
Etoricoxib—Dyspepsia—Topiramate—migraine	0.000146	0.000567	CcSEcCtD
Etoricoxib—Hypersensitivity—Gabapentin—migraine	0.000145	0.000564	CcSEcCtD
Etoricoxib—MAPK14—Developmental Biology—SCN2A—migraine	0.000145	0.00648	CbGpPWpGaD
Etoricoxib—Diarrhoea—Timolol—migraine	0.000145	0.000562	CcSEcCtD
Etoricoxib—CYP2C9—cardiovascular system—migraine	0.000145	0.0231	CbGeAlD
Etoricoxib—MAPK14—TGF-beta Signaling Pathway—TGFBR2—migraine	0.000144	0.00645	CbGpPWpGaD
Etoricoxib—Decreased appetite—Topiramate—migraine	0.000144	0.00056	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Topiramate—migraine	0.000143	0.000556	CcSEcCtD
Etoricoxib—Fatigue—Topiramate—migraine	0.000143	0.000555	CcSEcCtD
Etoricoxib—Pain—Topiramate—migraine	0.000142	0.000551	CcSEcCtD
Etoricoxib—Constipation—Topiramate—migraine	0.000142	0.000551	CcSEcCtD
Etoricoxib—Asthenia—Gabapentin—migraine	0.000141	0.000549	CcSEcCtD
Etoricoxib—Nausea—Valproic Acid—migraine	0.000141	0.000548	CcSEcCtD
Etoricoxib—Dizziness—Timolol—migraine	0.00014	0.000543	CcSEcCtD
Etoricoxib—Pruritus—Gabapentin—migraine	0.000139	0.000541	CcSEcCtD
Etoricoxib—MAPK14—Glucocorticoid receptor regulatory network—FOS—migraine	0.000137	0.00614	CbGpPWpGaD
Etoricoxib—CYP2E1—cardiovascular system—migraine	0.000137	0.0219	CbGeAlD
Etoricoxib—Feeling abnormal—Topiramate—migraine	0.000137	0.000531	CcSEcCtD
Etoricoxib—MAPK14—Amyotrophic lateral sclerosis (ALS)—TNF—migraine	0.000137	0.00611	CbGpPWpGaD
Etoricoxib—Gastrointestinal pain—Topiramate—migraine	0.000135	0.000526	CcSEcCtD
Etoricoxib—Diarrhoea—Gabapentin—migraine	0.000135	0.000524	CcSEcCtD
Etoricoxib—Vomiting—Timolol—migraine	0.000134	0.000523	CcSEcCtD
Etoricoxib—MAPK14—MyD88 cascade initiated on plasma membrane—FOS—migraine	0.000133	0.00597	CbGpPWpGaD
Etoricoxib—Rash—Timolol—migraine	0.000133	0.000518	CcSEcCtD
Etoricoxib—Dermatitis—Timolol—migraine	0.000133	0.000518	CcSEcCtD
Etoricoxib—CYP2D6—brainstem—migraine	0.000133	0.0212	CbGeAlD
Etoricoxib—Headache—Timolol—migraine	0.000132	0.000515	CcSEcCtD
Etoricoxib—MAPK14—Developmental Biology—MEF2D—migraine	0.000132	0.00593	CbGpPWpGaD
Etoricoxib—MAPK14—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—FOS—migraine	0.000132	0.00591	CbGpPWpGaD
Etoricoxib—Urticaria—Topiramate—migraine	0.000132	0.000511	CcSEcCtD
Etoricoxib—Abdominal pain—Topiramate—migraine	0.000131	0.000509	CcSEcCtD
Etoricoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOS—migraine	0.00013	0.00583	CbGpPWpGaD
Etoricoxib—Dizziness—Gabapentin—migraine	0.00013	0.000506	CcSEcCtD
Etoricoxib—MAPK14—MyD88 dependent cascade initiated on endosome—FOS—migraine	0.00013	0.0058	CbGpPWpGaD
Etoricoxib—MAPK14—BDNF signaling pathway—BDNF—migraine	0.000129	0.00579	CbGpPWpGaD
Etoricoxib—MAPK14—TCR Signaling Pathway—FOS—migraine	0.000127	0.0057	CbGpPWpGaD
Etoricoxib—PTGS2—cardiovascular system—migraine	0.000126	0.0202	CbGeAlD
Etoricoxib—MAPK14—TWEAK Signaling Pathway—TNF—migraine	0.000126	0.00564	CbGpPWpGaD
Etoricoxib—Nausea—Timolol—migraine	0.000126	0.000488	CcSEcCtD
Etoricoxib—Vomiting—Gabapentin—migraine	0.000125	0.000487	CcSEcCtD
Etoricoxib—MAPK14—Corticotropin-releasing hormone—FOS—migraine	0.000125	0.0056	CbGpPWpGaD
Etoricoxib—MAPK14—Toll Like Receptor 9 (TLR9) Cascade—FOS—migraine	0.000125	0.0056	CbGpPWpGaD
Etoricoxib—Rash—Gabapentin—migraine	0.000124	0.000483	CcSEcCtD
Etoricoxib—Dermatitis—Gabapentin—migraine	0.000124	0.000482	CcSEcCtD
Etoricoxib—Headache—Gabapentin—migraine	0.000123	0.000479	CcSEcCtD
Etoricoxib—MAPK14—MyD88:Mal cascade initiated on plasma membrane—FOS—migraine	0.000123	0.00551	CbGpPWpGaD
Etoricoxib—Hypersensitivity—Topiramate—migraine	0.000122	0.000474	CcSEcCtD
Etoricoxib—Asthenia—Topiramate—migraine	0.000119	0.000462	CcSEcCtD
Etoricoxib—MAPK14—MAPK Signaling Pathway—TGFBR2—migraine	0.000119	0.00532	CbGpPWpGaD
Etoricoxib—MAPK14—MyD88-independent cascade—FOS—migraine	0.000118	0.00528	CbGpPWpGaD
Etoricoxib—Pruritus—Topiramate—migraine	0.000117	0.000456	CcSEcCtD
Etoricoxib—Nausea—Gabapentin—migraine	0.000117	0.000455	CcSEcCtD
Etoricoxib—MAPK14—Toll-like Receptor Signaling Pathway—FOS—migraine	0.000115	0.00516	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—BDNF—migraine	0.000114	0.00512	CbGpPWpGaD
Etoricoxib—Diarrhoea—Topiramate—migraine	0.000113	0.000441	CcSEcCtD
Etoricoxib—MAPK14—Angiopoietin receptor Tie2-mediated signaling—TNF—migraine	0.00011	0.0049	CbGpPWpGaD
Etoricoxib—Dizziness—Topiramate—migraine	0.00011	0.000426	CcSEcCtD
Etoricoxib—MAPK14—Activated TLR4 signalling—FOS—migraine	0.000106	0.00475	CbGpPWpGaD
Etoricoxib—Vomiting—Topiramate—migraine	0.000105	0.000409	CcSEcCtD
Etoricoxib—Rash—Topiramate—migraine	0.000104	0.000406	CcSEcCtD
Etoricoxib—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—migraine	0.000104	0.00467	CbGpPWpGaD
Etoricoxib—Dermatitis—Topiramate—migraine	0.000104	0.000406	CcSEcCtD
Etoricoxib—Headache—Topiramate—migraine	0.000104	0.000403	CcSEcCtD
Etoricoxib—PTGS2—Selenium Micronutrient Network—MTHFR—migraine	0.000103	0.00463	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—BDNF—migraine	0.000103	0.00462	CbGpPWpGaD
Etoricoxib—MAPK14—Oxidative Stress Induced Senescence—FOS—migraine	0.000102	0.00456	CbGpPWpGaD
Etoricoxib—MAPK14—Cardiac Hypertrophic Response—TNF—migraine	0.000102	0.00454	CbGpPWpGaD
Etoricoxib—MAPK14—Toll Like Receptor 4 (TLR4) Cascade—FOS—migraine	9.99e-05	0.00447	CbGpPWpGaD
Etoricoxib—Nausea—Topiramate—migraine	9.84e-05	0.000382	CcSEcCtD
Etoricoxib—PTGS2—Spinal Cord Injury—BDNF—migraine	9.7e-05	0.00434	CbGpPWpGaD
Etoricoxib—MAPK14—TGF-beta Signaling Pathway—FOS—migraine	9.38e-05	0.0042	CbGpPWpGaD
Etoricoxib—CYP2E1—head—migraine	9.28e-05	0.0148	CbGeAlD
Etoricoxib—MAPK14—Regulation of toll-like receptor signaling pathway—FOS—migraine	9e-05	0.00403	CbGpPWpGaD
Etoricoxib—MAPK14—Toll-Like Receptors Cascades—FOS—migraine	8.9e-05	0.00398	CbGpPWpGaD
Etoricoxib—CYP2E1—nervous system—migraine	8.8e-05	0.0141	CbGeAlD
Etoricoxib—MAPK14—BDNF signaling pathway—FOS—migraine	8.75e-05	0.00391	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—migraine	8.74e-05	0.00391	CbGpPWpGaD
Etoricoxib—PTGS2—head—migraine	8.54e-05	0.0137	CbGeAlD
Etoricoxib—CYP2E1—central nervous system—migraine	8.47e-05	0.0135	CbGeAlD
Etoricoxib—CYP2E1—cerebellum—migraine	8.28e-05	0.0132	CbGeAlD
Etoricoxib—PTGS2—nervous system—migraine	8.1e-05	0.0129	CbGeAlD
Etoricoxib—MAPK14—Insulin Signaling—FOS—migraine	8.04e-05	0.0036	CbGpPWpGaD
Etoricoxib—MAPK14—EGF/EGFR Signaling Pathway—FOS—migraine	7.96e-05	0.00356	CbGpPWpGaD
Etoricoxib—PTGS2—central nervous system—migraine	7.8e-05	0.0125	CbGeAlD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—ESR1—migraine	7.74e-05	0.00346	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—FOS—migraine	7.73e-05	0.00346	CbGpPWpGaD
Etoricoxib—PTGS2—cerebellum—migraine	7.62e-05	0.0122	CbGeAlD
Etoricoxib—PTGS2—Aryl Hydrocarbon Receptor—TNF—migraine	7.49e-05	0.00335	CbGpPWpGaD
Etoricoxib—CYP2D6—head—migraine	7.35e-05	0.0117	CbGeAlD
Etoricoxib—MAPK14—MicroRNAs in cardiomyocyte hypertrophy—TNF—migraine	7.24e-05	0.00324	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular Senescence—FOS—migraine	7.13e-05	0.00319	CbGpPWpGaD
Etoricoxib—CYP3A4—nervous system—migraine	7.08e-05	0.0113	CbGeAlD
Etoricoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—migraine	7e-05	0.00313	CbGpPWpGaD
Etoricoxib—CYP2D6—nervous system—migraine	6.96e-05	0.0111	CbGeAlD
Etoricoxib—CYP3A4—central nervous system—migraine	6.81e-05	0.0109	CbGeAlD
Etoricoxib—CYP2E1—brain—migraine	6.72e-05	0.0107	CbGeAlD
Etoricoxib—CYP2D6—central nervous system—migraine	6.7e-05	0.0107	CbGeAlD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—migraine	6.6e-05	0.00295	CbGpPWpGaD
Etoricoxib—CYP2D6—cerebellum—migraine	6.55e-05	0.0105	CbGeAlD
Etoricoxib—PTGS2—Spinal Cord Injury—FOS—migraine	6.55e-05	0.00293	CbGpPWpGaD
Etoricoxib—MAPK14—Toll-like Receptor Signaling Pathway—TNF—migraine	6.2e-05	0.00277	CbGpPWpGaD
Etoricoxib—PTGS2—brain—migraine	6.19e-05	0.0099	CbGeAlD
Etoricoxib—MAPK14—Signaling Pathways—RAMP1—migraine	5.4e-05	0.00242	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CALCRL—migraine	5.4e-05	0.00242	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—FOS—migraine	5.39e-05	0.00241	CbGpPWpGaD
Etoricoxib—CYP2D6—brain—migraine	5.32e-05	0.00851	CbGeAlD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—migraine	4.95e-05	0.00221	CbGpPWpGaD
Etoricoxib—MAPK14—Regulation of toll-like receptor signaling pathway—TNF—migraine	4.84e-05	0.00216	CbGpPWpGaD
Etoricoxib—PTGS2—Selenium Micronutrient Network—TNF—migraine	4.45e-05	0.00199	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor—TNF—migraine	4.24e-05	0.0019	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	4.24e-05	0.0019	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—TNF—migraine	4.16e-05	0.00186	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—HTR1D—migraine	3.93e-05	0.00176	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—NOTCH4—migraine	3.79e-05	0.0017	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TNF—migraine	3.75e-05	0.00168	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—HTR2B—migraine	3.65e-05	0.00163	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—TNF—migraine	3.52e-05	0.00158	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—PGR—migraine	3.47e-05	0.00155	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—NOTCH3—migraine	3.22e-05	0.00144	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—LRP1—migraine	3.21e-05	0.00144	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—CACNA1A—migraine	3.13e-05	0.0014	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—CACNA1A—migraine	2.95e-05	0.00132	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—LRP1—migraine	2.93e-05	0.00131	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—FOS—migraine	2.88e-05	0.00129	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—NOTCH4—migraine	2.47e-05	0.0011	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—migraine	2.4e-05	0.00107	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—HTR1B—migraine	2.38e-05	0.00106	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—HTR1A—migraine	2.29e-05	0.00102	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—CACNA1A—migraine	2.27e-05	0.00102	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—PGR—migraine	2.25e-05	0.00101	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TAC1—migraine	2.25e-05	0.00101	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—NPS—migraine	2.25e-05	0.00101	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—HTR2C—migraine	2.21e-05	0.000989	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—EDNRA—migraine	2.15e-05	0.000963	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—NOTCH3—migraine	2.1e-05	0.000938	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CACNA1A—migraine	2.09e-05	0.000935	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CACNA1A—migraine	2.07e-05	0.000927	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CALCA—migraine	2.07e-05	0.000926	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—HTR7—migraine	1.94e-05	0.000867	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CALCA—migraine	1.89e-05	0.000845	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—ESR1—migraine	1.85e-05	0.000829	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CACNA1A—migraine	1.77e-05	0.000792	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—TNF—migraine	1.75e-05	0.000785	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—FOS—migraine	1.68e-05	0.000751	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TGFBR2—migraine	1.67e-05	0.000746	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—TGFBR2—migraine	1.52e-05	0.000681	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CACNA1A—migraine	1.37e-05	0.000611	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—HTR2A—migraine	1.36e-05	0.000607	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—MTHFR—migraine	1.24e-05	0.000553	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—ESR1—migraine	1.2e-05	0.000539	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—MTHFR—migraine	1.03e-05	0.000463	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—MTHFR—migraine	9.74e-06	0.000436	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—MTHFR—migraine	7.52e-06	0.000336	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—MTHFR—migraine	6.91e-06	0.000309	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—MTHFR—migraine	6.85e-06	0.000307	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—MTHFR—migraine	5.86e-06	0.000262	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—MTHFR—migraine	4.52e-06	0.000202	CbGpPWpGaD
